Skip to content

Clinical significance of IL-17 expression in obese asthma

Clinical significance of IL-17 expression in obese asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006972
Enrollment
Unknown
Registered
2015-08-23
Start date
2012-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

lean asthma group (stable):no intervention
overweight/obese asthma group (stable):no intervention
lean asthma group (acute):no intervention
overweight/obese asthma group (acute):no intervention

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 69 Years

Inclusion criteria

Inclusion criteria: adult patients with brochial asthma diagonized according to GINA (2012)

Exclusion criteria

Exclusion criteria: Stable asthma patients should have no asthma exacerbation, respiratory tract infection or systemic corticosteroid use in the preceding 4 weeks and are not accompanied by parenchymal lung disease apparent on chest radiography, diabetes mellitus, cardiovascular disease, pregnancy, autoimmune diseases and tumors. Patients, in whom sputum induction could not be achieved, were also excluded. Acute asthma patients, who need endotracheal intubation or tracheostomy and mechanical ventilation and in whom sputum induction could not be achieved are excluded.

Design outcomes

Primary

MeasureTime frame
sputum neutrophil percentage;sputum eosinophil percentage;sputum IL-17 concentration;plasma IL-17 concentration;

Secondary

MeasureTime frame
forced expiratory volume in 1 second;forced vital capacity;asthma control questionnaire score;inhaled corticosteroid dose;Beck Depression Inventory II score;proportion of patients with obstructive sleep apnea;proportion of patients with gastro-esophageal reflux;proportion of patients with neutrophilic asthma;proportion of patients with eosinophilic asthma;pulse;respiratroy rate;arterial oxygen saturation;

Countries

China

Contacts

Public ContactHu Chenping
1284530031@qq.com+86 15052646661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026